Similarly, theranostic imaging could help monitor the efficacy of emergent molecular therapies (e.g., the use of progesterone receptor modulators for uterine fibroids), whereas intraoperative imaging could help improve accuracy during the resection of benign lesions such as uterine fibroids and endometriomas (7). The gene discussed is PGR; the disease is uterine corpus leiomyoma.